Mosztbacher D, Sahin-Toth M
Pancreatology. 2021; 21(2):342-352.
PMID: 33526384
PMC: 7969449.
DOI: 10.1016/j.pan.2021.01.007.
Paliwal S, Bhaskar S, Chandak G
World J Gastroenterol. 2014; 20(46):17314-23.
PMID: 25516642
PMC: 4265589.
DOI: 10.3748/wjg.v20.i46.17314.
Mastoraki A, Tzortzopoulou A, Tsela S, Danias N, Sakorafas G, Smyrniotis V
J Gastrointest Cancer. 2013; 45(1):22-6.
PMID: 24242859
DOI: 10.1007/s12029-013-9559-6.
Ferec C, Cutting G
Cold Spring Harb Perspect Med. 2012; 2(12):a009480.
PMID: 23209179
PMC: 3543074.
DOI: 10.1101/cshperspect.a009480.
Petronella N, Drouin G
Hum Genet. 2012; 131(11):1739-49.
PMID: 22752798
DOI: 10.1007/s00439-012-1196-9.
Complete analysis of the human mesotrypsinogen gene (PRSS3) in patients with chronic pancreatitis.
Rosendahl J, Teich N, Kovacs P, Szmola R, Bluher M, Gress T
Pancreatology. 2010; 10(2-3):243-9.
PMID: 20484962
PMC: 2899151.
DOI: 10.1159/000243769.
Genetic mechanisms underlying the pathogenesis of tropical calcific pancreatitis.
Mahurkar S, Reddy D, Venkat Rao G, Chandak G
World J Gastroenterol. 2009; 15(3):264-9.
PMID: 19140225
PMC: 2653322.
DOI: 10.3748/wjg.15.264.
Genetic background of pancreatitis.
Hirota M, Ohmuraya M, Baba H
Postgrad Med J. 2006; 82(974):775-8.
PMID: 17148697
PMC: 2653919.
DOI: 10.1136/pgmj.2006.050591.
The role of trypsin, trypsin inhibitor, and trypsin receptor in the onset and aggravation of pancreatitis.
Hirota M, Ohmuraya M, Baba H
J Gastroenterol. 2006; 41(9):832-6.
PMID: 17048046
DOI: 10.1007/s00535-006-1874-2.
Mutations of human cationic trypsinogen (PRSS1) and chronic pancreatitis.
Teich N, Rosendahl J, Toth M, Mossner J, Sahin-Toth M
Hum Mutat. 2006; 27(8):721-30.
PMID: 16791840
PMC: 2793115.
DOI: 10.1002/humu.20343.
Biochemical models of hereditary pancreatitis.
Sahin-Toth M
Endocrinol Metab Clin North Am. 2006; 35(2):303-12, ix.
PMID: 16632094
PMC: 1602208.
DOI: 10.1016/j.ecl.2006.02.002.
Chymotrypsin C (caldecrin) stimulates autoactivation of human cationic trypsinogen.
Nemoda Z, Sahin-Toth M
J Biol Chem. 2006; 281(17):11879-86.
PMID: 16505482
PMC: 1586167.
DOI: 10.1074/jbc.M600124200.
Human mesotrypsin defies natural trypsin inhibitors: from passive resistance to active destruction.
Sahin-Toth M
Protein Pept Lett. 2005; 12(5):457-64.
PMID: 16029158
PMC: 1488880.
DOI: 10.2174/0929866054395356.
The tetra-aspartate motif in the activation peptide of human cationic trypsinogen is essential for autoactivation control but not for enteropeptidase recognition.
Nemoda Z, Sahin-Toth M
J Biol Chem. 2005; 280(33):29645-52.
PMID: 15970597
PMC: 1420407.
DOI: 10.1074/jbc.M505661200.
Genetic and biochemical characterization of the E32del polymorphism in human mesotrypsinogen.
Nemoda Z, Teich N, Hugenberg C, Sahin-Toth M
Pancreatology. 2005; 5(2-3):273-8.
PMID: 15855826
PMC: 1401494.
DOI: 10.1159/000085282.
Mutations in anionic trypsinogen gene are not associated with tropical calcific pancreatitis.
Idris M, Bhaskar S, Reddy D, Mani K, Rao G, Singh L
Gut. 2005; 54(5):728-9.
PMID: 15831926
PMC: 1774499.
DOI: 10.1136/gut.2004.055335.
